BaSES Trial: Basel Starch Evaluation in Sepsis
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Jan 6, 2006
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients with suspected or proven infection and 2 of the following 6 criteria:
- • Body temperature \<36 or \>38.3° celsius
- • Heart rate \> 90 beats/min
- • Tachypnea \> 20/min or a arterial pCO2 below 4.25 kPa
- • White blood cell count higher than 12.000 or below 4.000 or more than 10% immature forms
- • Systolic blood pressure \<90 mmHg or mean arterial pressure \< 65 mmHg
- • Altered mental state or oliguria
- Exclusion Criteria:
- • Pregnancy
- • Age below 18
- • Allergy against Hydroxyethyl starch
- • Chronic renal insufficiency
Trial Officials
Martin Siegemund, MD
Principal Investigator
Anaesthesia and Intensive Care, State Hospital, CH-5404 Baden, Switzerland
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Basel, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials